Contact Us

About

The Beond Ibogaine Research and Policy Institute advances ibogaine-assisted treatments through research, expertise, and advocacy. It improves efficacy and application for conditions such as PTSD, TBI, depression, anxiety, opioid dependency, alcohol dependency, and stimulant and ketamine addictions.

VISION

A Vision for Transforming Policy and Public Understanding


The institute bridges clinical innovation, research, and policy, offering evidence-based insights to guide policymakers. This work is essential to shaping policies that prioritize safety, efficacy, and ethical use while expanding access to this transformative therapy.

Evidence-Based Advocacy

By analyzing data from 3,500+ ibogaine treatments and longitudinal studies, the institute provides evidence on safety and effectiveness, shaping policy briefs, recommendations, and educational materials for policymakers.

Informing Policy Development

The institute guides policymakers on ibogaine’s clinical use, safety, and public health impact, offering data-driven guidelines for informed legislation.

Engaging Decision-Makers

The institute collaborates with officials, regulators, and advocates to promote ibogaine therapy. It provides expert testimony, workshops, and discussions on its potential for mental health and addiction treatment.

Expanding Public Access

By advocating for policy changes that support clinical trials, research funding, and regulatory approvals, the institute helps pave the way for broader access to ibogaine therapy in ethical and controlled environments

Promoting Safety 
and Standards

The institute’s recommendations emphasize the importance of advanced clinical environments, highly trained professionals, and rigorous safety protocols. Policymakers can use these insights to develop standards that ensure public safety and build trust in this emerging treatment.

FOUNDATION

Data as the Foundation for Advocacy and Impact

The institute’s approach is deeply rooted in data collection and analysis. Using advanced digital tools, Beond collects 176 data points per treatment and employs remote tools for longitudinal monitoring, providing a comprehensive understanding of patient outcomes.

This robust dataset allows the institute to:

Identify Trends and Patterns

Analyze patient responses to ibogaine across diverse conditions and demographics.

Refine Treatment Protocols

Optimize dosing, safety measures, and patient preparation to maximize therapeutic benefits.

Provide Actionable Insights

Develop targeted recommendations for state and federal agencies using real-world data. This approach aligns with healthcare innovators to drive policy changes and public health initiatives.

TEAM

A Multidisciplinary Team Driving Change
The institute’s mission is powered by a world-class team of experts whose collective experience ensures a holistic approach to research and advocacy:

Shirley
Cheung, PhD

A neuroscientist specializing in the neurobiological mechanisms of ibogaine, Dr. Cheung leads the institute’s data analysis and research initiatives. Her work translates complex scientific findings into accessible insights for policymakers and stakeholders.

Dr. Edgar
Diaz, MD

An expert in the medical and psychological dimensions of ibogaine therapy, Dr. Diaz ensures that clinical recommendations are grounded in real-world patient care.

Dr. Alberto
Sola, MD

With over 20 years of experience treating patients with ibogaine, Dr. Sola is a pioneer in the field. His clinical expertise shapes safety protocols, therapeutic standards, and guides responsible medical practice globally.

Joseph
Barsuglia, PhD

A clinical psychologist and expert in psychedelic therapies, Dr. Barsuglia researches the psychological benefits of ibogaine. His expertise spans healthcare innovation, neuropsychology, psychotherapy, psychedelic-assisted therapies, alternative healing, and spiritual direction.

Roadmap

A Roadmap for Policymakers
and Elected Officials

Policymakers and elected officials stand to benefit significantly from the institute’s work, gaining access to:

Comprehensive Research

Insights into the safety and efficacy of ibogaine, supported by data from thousands of treatments and longitudinal studies.

Clear
Guidelines

Recommendations for developing regulatory frameworks that prioritize safety and ethical use.

Public Health Solutions

Evidence-based strategies to address the opioid crisis, mental health challenges, and other pressing issues.

Educational
Resources

Workshops, policy briefs, and expert consultations that provide a deeper understanding of ibogaine’s potential
By engaging with the institute, policymakers can make informed decisions that reflect the latest research, address public health needs, and build pathways for responsible innovation in psychedelic-assisted therapies.

Transforming
Mental Health

The Beond Ibogaine Research and Policy Institute is at the forefront of a transformative movement in mental health and addiction treatment.

By combining rigorous research, clinical expertise, and strategic advocacy, the institute not only improves the performance of ibogaine-assisted therapies but also provides policymakers with the tools they need to shape thoughtful, evidence-based legislation.

Together
WE HEAL

Together, this work will help more people heal, grow, and thrive, establishing a new standard for the ethical and effective use of ibogaine. 

© 2025 Beond Ibogaine Research & Policy Institute. All rights reserved.